Polysaccharides, Microbial G Morris and S Harding, University of Nottingham, Sutton Bonington, UK

Total Page:16

File Type:pdf, Size:1020Kb

Polysaccharides, Microbial G Morris and S Harding, University of Nottingham, Sutton Bonington, UK Polysaccharides, Microbial G Morris and S Harding, University of Nottingham, Sutton Bonington, UK ª 2009 Elsevier Inc. All rights reserved. Defining Statement Dextrans Introduction Scleroglucan and Schizophyllan Xanthan Bacterial Alginates Xylinan (Acetan) Bacterial Hyaluronic Acid Gellan, XM6, and Curdlan Polysaccharide Vaccines Cyanobacterial Polysaccharides Conclusion Pullulan Further Reading Glossary molecular weight averaged over the number capsular polysaccharide (CPS) An exocellular concentrations of each species. It can be determined by polysaccharide secreted in such a large amount that it techniques such as osmotic pressure, size exclusion encapsulates a microorganism, facilitating adhesion chromatography coupled to multiangle light scattering and helping screen from immune response. Sometimes (SEC-MALLs) or analytical ultracentrifugation. a distinction is made with more loosely attached molecular weight – weight average, Mw (Da or À1 polysaccharides ‘released polysaccharide’ (RPS). g mol ) In a mixture of macromolecules Mw is the epimerase An enzyme that converts mannuronic acid molecular weight averaged over the weight residues to guluronic acid residues in alginates. concentrations of each species. It can be determined by intrinsic viscosity, [h] (ml gÀ1) A measure of a techniques such as size exclusion chromatography particle’s conformation and volume occupancy in coupled to multiangle light scattering (SEC-MALLs) or solution. analytical ultracentrifugation. Mark–Houwink ‘a’ parameter A measure of the non-Newtonian fluid A fluid in which viscosity conformation of a macromolecule, and determined from changes with applied strain, an example of which is measurements of solution viscosity and molecular shear thinning. weight. Limits are 0 (sphere), 1.8 (rod), with values persistence length, Lp (nm) A measure of the flexibility 0.5–0.8 for a flexible coil-like molecule. of a linear macromolecule ranging from 2 nm for a very molecular weight (Da or g molÀ1) Popular terminology flexible molecule to 200 nm for very stiff. for ‘molar mass’ – the mass of 1 mol (6.023 Â 1023) polydispersity index The ratio of the weight average molecules. molecular weight to the number average molecular molecular weight – number average, Mn (Da or weight, Mw/Mn. Minimum value ¼ 1. À1 g mol ) In a mixture of macromolecules Mn is the Abbreviations GRAS generally regarded as safe CPS capsular polysaccharide HA hyaluronic acid GDP guanosine diphosphate RPS released polysaccharide Defining Statement properties. We consider the structure, properties, extraction, production, modification, and applications of commercially Microbial polysaccharides are used for food, pharmaceutical, available microbial polysaccharides including xanthan, xyli- and medical applications: this wide range of usefulness nan, gellan, curdlan, pullulan, dextran, scleroglucan, derives from the great diversity in structural and functional schizophyllan, and cyanobacterial polysaccharides. 482 Applied Microbiology: Industrial | Polysaccharides, Microbial 483 Introduction They may also prevent phagocytosis by other micro- organisms or the cells of the immune system. The capsular Over the last two decades there has been an expanding polysaccharides (CPSs) are often highly immunogenic, and interest in polysaccharides produced extracellularly by may have evolved their unusual diversity as a way of microorganisms for food, pharmaceutical, and medical avoiding antibody responses: advantage of this feature can use, including vaccines. The wide range of their useful- be taken in the development of vaccines. They also have a ness derives from the great diversity in structural and role in adhesion and penetration of the host. In the case of functional properties even though they are built up from plants this involves interaction with polysaccharide struc- very similar building blocks: the pyranose or furanose tures in the cell walls and there are possibilities of specific carbohydrate ring structure. One can have rod-shaped interactions. Plant lectins (glycoproteins) that have specific molecules like schizophyllan and scleroglucan from the binding properties with respect to carbohydrate structures fungi Schizophyllan commue and Sclerotium rolfsii, respec- may play a part in this and in the general defense of plants tively, linear random coil type structures like pullulan against bacterial infection. from the fungus Aureobasidium pullulans, and intermediate Some secreted polysaccharides can be involved in structures such as alginates from the bacterium pathogenicity. Pseudomonas aeruginosa, commonly found in Azotobacter vinelandii. One can have highly electronegative respiratory tract infections, produces alginate which con- or ‘polyanionic’ molecules like xanthan secreted by tributes to blockage in the respiratory tract, and leads to Xanthomonas campestris or neutral polysaccharides like further infection, and similar blockages of phloem in plants dextrans from the bacteria Leuconostoc mesenteroides. have also been described. However, the secreted polysac- Polysaccharides made by microrganisms are secreted charides themselves present virtually no known toxicity from the cell to form a layer over the surface of the problems and many are harvestable at low cost in large organism, often of substantial depth in comparison with quantities, making them attractive for biotechnological use. the cell dimensions (Figure 1). Because of their position Microbial products are very important in all aspects of they are characterized as exopolysaccharides, to distin- polysaccharide biotechnology. They range from bulk guish them from any polysaccharides that might be found materials such as xanthan, priced at about US$14 per kg, within the cell. The functions are thought to be mainly used mainly in food applications, to cyclic dextrans, protective, either as a general physical barrier preventing valued at about US$50 per kg and used in high-value access of harmful substances, or more specific as a way of applications in research and pharmaceuticals. binding and neutralizing bacteriophage. In appropriate Certain microbes are known to produce nearly all the environments they may prevent dehydration. major plant polysaccharides such as glucans, alginate-like materials, and even cellulose – as well as the complex bacteria-specific materials. Genetic manipulation of bac- teria has been studied for longer and is in general much easier than for higher organisms, so that they are an P obvious target for both manipulation of biosynthetic path- ways and the expression of heterologous genes to produce especially desirable enzymes. Polysaccharides are not of course under the direct control of genetic material in the way that enzymes are, and must be approached indirectly by manipulating the biosynthetic or degradation path- ways by way of the enzymes responsible: there is currently great scope for this approach. In addition, since there are now fermentation processes involving the large-scale growth of bacteria, all the advances in this field can be achieved by biotechnology. There are also limitations. It is unlikely that large- scale fermentation could ever compete with existing pro- cesses for pectin manufacture, for example, since Figure 1 Exocellular or ‘capsular’ polysaccharide layer processors currently use waste by-products from other (labeled P) from Streptococcus pneumoniae. Adapted from processes as their raw material. This is quite apart from Skov-Sørensen UB, Blom J, Birch-Andersen A, and Henrichsen J the inherent costs of large-scale fermenters in comparison (1988) Ultrastructural localization of capsules, cell wall with simple extraction processes. It follows that bacterial polysaccharide, cell wall proteins and F antigen in pneumococci. Infection and Immunity 56: 1890–1896. Reproduced with products must have particularly useful properties in order permission from the American Society for Microbiology. to justify their probable greater cost. 484 Applied Microbiology: Industrial | Polysaccharides, Microbial This article looks at the production, properties, and trisaccharide involving mannose and acetylated biomodifications where appropriate of a selected range mannose: of important microbial polysaccharides because it is impossible to cover each substance comprehensively. -D-Manpð1!4Þ -D-GlcpA Instead, we focus on xanthan as our main example ð1!2Þ -D-Manp-6-OAcetylð1!3Þ because of its commercial importance but also consider with some of the terminal -D-Manp residues substituted xanthan-like exopolysaccharides such as gellan, xm6, – at positions C4 and C6 by pyruvate (CH3.CO.COO ). curdlan, xylinan, and the increasingly important group Thus xanthan (except under highly acidic conditions) is, of cyanobacterial polysaccharides – also xanthan-like – like alginate, a highly charged polyanion. Figure 2(a) as well as pullulan, dextrans, scleroglucan, schizophyllan, shows the Haworth projection of a (pyruvalated) alternate microbial hyaluronic acid (HA), and bacterial alginates repeat section of xanthan. as representative examples. We complete our review It is not only charge repulsion effects that convey on with a look at the use and potential further use of xanthan an extended rigid rod conformation. X-ray fiber exopolysaccharides as vaccines against serious diseases diffraction studies have shown the presence of some helical such as meningitis in infants. structure although there is still uncertainty as to whether this helix is a coaxial duplex or just a single chain one, with the projecting trisaccharides
Recommended publications
  • Effect of Intake of Food Hydrocolloids of Bacterial Origin on the Glycemic Response in Humans: Systematic Review and Narrative Synthesis
    nutrients Review Effect of Intake of Food Hydrocolloids of Bacterial Origin on the Glycemic Response in Humans: Systematic Review and Narrative Synthesis Norah A. Alshammari 1,2, Moira A. Taylor 3, Rebecca Stevenson 4 , Ourania Gouseti 5, Jaber Alyami 6 , Syahrizal Muttakin 7,8, Serafim Bakalis 5, Alison Lovegrove 9, Guruprasad P. Aithal 2 and Luca Marciani 2,* 1 Department of Clinical Nutrition, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia; [email protected] 2 Translational Medical Sciences and National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham NG7 2UH, UK; [email protected] 3 Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen’s Medical Centre, National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham NG7 2UH, UK; [email protected] 4 Precision Imaging Beacon, University of Nottingham, Nottingham NG7 2UH, UK; [email protected] 5 Department of Food Science, University of Copenhagen, DK-1958 Copenhagen, Denmark; [email protected] (O.G.); [email protected] (S.B.) 6 Department of Diagnostic Radiology, Faculty of Applied Medical Science, King Abdulaziz University (KAU), Jeddah 21589, Saudi Arabia; [email protected] 7 Indonesian Agency for Agricultural Research and Development, Jakarta 12540, Indonesia; Citation: Alshammari, N.A.; [email protected] Taylor, M.A.; Stevenson, R.; 8 School of Chemical Engineering, University of Birmingham, Birmingham B15 2TT, UK Gouseti, O.; Alyami, J.; Muttakin, S.; 9 Rothamsted Research, Harpenden, Hertfordshire AL5 2JQ, UK; [email protected] Bakalis, S.; Lovegrove, A.; Aithal, G.P.; * Correspondence: [email protected]; Tel.: +44-115-823-1248 Marciani, L.
    [Show full text]
  • Pharmaceutical Compositions of Rifaximin Pharmazeutische Rifaximin-Zusammensetzungen Compositions Pharmaceutiques De Rifaximine
    (19) TZZ Z__ T (11) EP 2 011 486 B2 (12) NEW EUROPEAN PATENT SPECIFICATION After opposition procedure (45) Date of publication and mention (51) Int Cl.: of the opposition decision: A61K 9/20 (2006.01) A61K 31/44 (2006.01) 12.08.2015 Bulletin 2015/33 (45) Mention of the grant of the patent: 23.05.2012 Bulletin 2012/21 (21) Application number: 08252198.0 (22) Date of filing: 26.06.2008 (54) Pharmaceutical compositions of rifaximin Pharmazeutische Rifaximin-Zusammensetzungen Compositions pharmaceutiques de rifaximine (84) Designated Contracting States: (56) References cited: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR EP-A1- 0 616 808 EP-B1- 1 763 339 HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT WO-A-2006/094737 WO-A2-2006/039022 RO SE SI SK TR US-A- 6 140 355 US-A1- 2005 101 598 (30) Priority: 06.07.2007 IN KO09682007 • DUPONT ET AL: "Treatment of Travelers’ 23.06.2008 EP 08252158 Diarrhea: Randomized Trial Comparing Rifaximin, Rifaximin Plus Loperamide, and (43) Date of publication of application: Loperamide Alone" CLINICAL 07.01.2009 Bulletin 2009/02 GASTROENTEROLOGY AND HEPATOLOGY, AMERICAN GASTROENTEROLOGICAL (60) Divisional application: ASSOCIATION, US, vol. 5, no. 4, 17 April 2007 11176043.5 / 2 420 226 (2007-04-17), pages 451-456, XP022029177 ISSN: 14186563.4 / 2 837 378 1542-3565 • ARYA ET AL: "Rifaximin-the promising anti- (73) Proprietor: Lupin Ltd. microbial for enteric infections" JOURNAL OF Mumbai, Maharashtra 400 098 (IN) INFECTION, ACADEMIC PRESS, LONDON, GB, vol.
    [Show full text]
  • Sia: the Sugar Code of Life
    Journal of General Surgery Open Access Full Text Article Research Article Sia: The Sugar Code of Life This article was published in the following Scient Open Access Journal: Journal of General Surgery Received November 05, 2017; Accepted November 27, 2017; Published December 04, 2017 Robert Skopec* Abstract Analyst-researcher, Dubnik, Slovakia, Europe Our cells are coated with sugar, and when it comes to cancer, that’s anything but sweet. In a recent talk at TEDxStanford, chemist Carolyn Bertozzi explained why. She studies sialic acid, a sugar that seems to deceive the immune system, allowing cancer cells to evade the body’s defenses. This work focuses on the complex, sugary structures surrounding human cells. That foliage-like coating, it turns out, can tell us a lot of our body – it even reveals a patient’s blood type. Sugar and carbohydrates are dangerous supporters of different types of cancer. Introduction As it can be seen from the information of the American Chemical Society (ACS), ideally, the immune system can figure out which cells are bad, attack them and protect the body from disease. In the case of cancer cells, though, a special sugary coating tricks the immune system into ignoring them. The sialic acid, a sugar that’s denser in cancer cells than in other cells. It seems deceive the immune system, allowing the cancer cells to evade the body’s defenses. Unnoticed and unchallenged, cancer cells are free to divideMonosaccharides and run wild inside - Sialic the acid/N-acetylneuraminicbody [1,2]. acid N-acetylneuraminic acid, also known as Sialic acid, is a key component of important amino sugars that mediate cellular communication.
    [Show full text]
  • SYNTHESIS and FUNCTIONALITY STUDY of NOVEL BIOMIMETIC N-GLYCAN POLYMERS KA KEUNG CHAN Bachelor of Science Appalachian State Univ
    SYNTHESIS AND FUNCTIONALITY STUDY OF NOVEL BIOMIMETIC N-GLYCAN POLYMERS KA KEUNG CHAN Bachelor of Science Appalachian State University May 2014 submitted in partial fulfillment of requirements for the degree of DOCTOR OF PHILOSOPHY IN CLINICAL AND BIOANALYTICAL CHEMISTRY at the CLEVELAND STATE UNIVERSITY May 2021 We hereby approve this dissertation for KA KEUNG CHAN Candidate for the Doctor of Philosophy in Clinical and Bioanalytical Chemistry degree for the Department of Chemistry and Cleveland State University’s College of Graduate Studies by ______________________________________________________ Xue-Long Sun, Ph.D., Dissertation Committee Chairperson Chemistry, 4/22/2021 Department & Date ____________________________________________________________ Aimin Zhou, Ph.D., Dissertation Committee Member Chemistry, 4/22/2021 Department & Date ____________________________________________________________ Bin Su, Ph.D., Dissertation Committee Member Chemistry, 4/22/2021 Department & Date ____________________________________________________________ David Anderson, Ph.D., Dissertation Committee Member Chemistry, 4/22/2021 Department & Date ____________________________________________________________ Moo-Yeal Lee, Ph.D., Dissertation Committee Member Chemical & Biomedical Engineering, 4/22/2021 Department & Date ____________________________________________________________ Aaron Severson, Ph.D., Dissertation Committee Member Biological, Geological and Environmental Sciences, 4/22/2021 Department & Date Date of Defense: 22 APRIL 2021 DEDICATION I dedicate the entirety of this degree to my family. My mother, Mrs. Yu Hung Cheung, to whom I owe the world and I unreservedly dedicate the entire of my life and achievements – thank you for everything that you have done for me. My fiancée, Ms. Mengni Xu, to whom I dedicate the rest of my life with my undying love – you deserve all of my achievements as much as I do. ACKNOWLEDGEMENT I extend my most sincere gratitude to Dr.
    [Show full text]
  • Pharmaceutical Compositions for Gastrointestinal Drug Delivery
    (19) TZZ Z¥_T (11) EP 2 942 053 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 11.11.2015 Bulletin 2015/46 A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61K 31/437 (2006.01) A61K 31/606 (2006.01) (2006.01) (2006.01) (21) Application number: 15156572.8 A61K 31/635 A61K 38/14 A61K 31/655 (2006.01) A61K 9/00 (2006.01) (2006.01) (22) Date of filing: 26.06.2008 A61K 9/24 (84) Designated Contracting States: • Kulkarni, Rajesh AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 411 042 Pune (IN) HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT • Kulkarni, Shirishkumar RO SE SI SK TR 411 042 Pune (IN) (30) Priority: 06.07.2007 IN KO09692007 (74) Representative: Hoffmann Eitle 24.06.2008 EP 08252164 Patent- und Rechtsanwälte PartmbB Arabellastraße 30 (62) Document number(s) of the earlier application(s) in 81925 München (DE) accordance with Art. 76 EPC: 08252197.2 / 2 011 487 Remarks: •This application was filed on 25-02-2015 as a (71) Applicant: Lupin Limited divisional application to the application mentioned Mumbai, Maharashtra 400 098 (IN) under INID code 62. •Claims filed after the date of filing of the application (72) Inventors: (Rule 68(4) EPC). • Jahagirdar, Harshal Anil 411 042 Pune (IN) (54) Pharmaceutical compositions for gastrointestinal drug delivery (57) A pharmaceutical composition, which compris- increase the residence time of the said pharmaceutical es a therapeutically effective amount of active principle composition and/or active principle (s) in the gastrointes- (s) or a pharmaceutically acceptable salt or enantiomer tinal tract.
    [Show full text]
  • Production of Microbial Polysaccharides for Use in Food
    See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/260201214 Production of microbial polysaccharides for use in food Chapter · March 2013 DOI: 10.1533/9780857093547.2.413 CITATIONS READS 21 4,237 1 author: Ioannis Giavasis University of Thessaly 39 PUBLICATIONS 588 CITATIONS SEE PROFILE Some of the authors of this publication are also working on these related projects: Archimedes View project Bacillus toyonensis View project All content following this page was uploaded by Ioannis Giavasis on 30 April 2018. The user has requested enhancement of the downloaded file. 1 2 3 4 5 6 16 7 8 9 Production of microbial polysaccharides 10 11 for use in food 12 Ioannis Giavasis, Technological Educational Institute of Larissa, Greece 13 14 DOI: 15 16 Abstract: Microbial polysaccharides comprise a large number of versatile 17 biopolymers produced by several bacteria, yeast and fungi. Microbial fermentation has enabled the use of these ingredients in modern food and 18 delivered polysaccharides with controlled and modifiable properties, which can be 19 utilized as thickeners/viscosifiers, gelling agents, encapsulation and film-making 20 agents or stabilizers. Recently, some of these biopolymers have gained special 21 interest owing to their immunostimulating/therapeutic properties and may lead to 22 the formation of novel functional foods and nutraceuticals. This chapter describes the origin and chemical identity, the biosynthesis and production process, and the 23 properties and applications of the most important microbial polysaccharides. 24 25 Key words: biosynthesis, food biopolymers, functional foods and nutraceuticals, 26 microbial polysaccharides, structure–function relationships. 27 28 29 16.1 Introduction 30 31 Microbial polysaccharides form a large group of biopolymers synthesized 32 by many microorganisms, as they serve different purposes including cell 33 defence, attachment to surfaces and other cells, virulence expression, energy 34 reserves, or they are simply part of a complex cell wall (mainly in fungi).
    [Show full text]
  • Sialic Acid (N-Acetylneuraminic Acid)
    Kim et al., J Glycomics Lipidomics 2014, 4:1 DOI: 10.4172/2153-0637.1000e116 Journal of Glycomics & Lipidomics Editorial Open Access Sialic Acid (N-Acetylneuraminic Acid) as the Functional Molecule for Differentiation between Animal and Plant Kingdom Cheorl-Ho Kim* Molecular and Cellular Glycobiology Unit, Department of Biological Sciences, College of Science, Sungkyunkwan University, Chunchun-Dong 300, Jangan-Gu, Suwon City, Kyunggi-Do 440-746, South Korea Keywords: Sialic acid; N-Acetylneuraminic acid; Echinoderms; Biological functionof Sialic Acids Animal-specific characters; Evolution The sialic acids or Neu5Ac are a group of 9-carbon monosacchride Organisms synthesize saccharides for carbohydrates, amino and synthesized in animals (Figure 2) [1]. Sialic acid-containing acids for proteins, fatty acid for lipids and nucleotides for nucleic glycoconjugates are initially synthesized from the deuterostome acids for the basic molecules. Recently, carbohydrates have been lineage of the echinoderms such as starfish and sea urchin up to the recognized as the 3rd life chain molecule in eukaryotic cells. One higher mammals. The echinoderms emerged some 500 million years of the biggest differences between the plant and animal kingdom ago. In insects and gastropod, the content of sialic acids are extremely would be the existence of the 9-carbon monosaccharide, sialic low [4-6] and protostome animals do not produce the sialic acids as forms of glycoconjugates [7]. In sialic acid-producing organisms, they acid or N-acetylneuraminic acids (Neu5Ac) (Figure 1). Even some occur as terminal residues in the glycoconjugates of cell surface and enterobacterial species produce the sialic acids, although their are components of glycoproteins, glycolipid such as ad gangliosides origins are postulated to be probably derived from the bacteria-host and glycosaminoglycan ubiquitously present in mammals and lower interactions during long evolution.
    [Show full text]
  • Synthesis, Characterization and Properties of Novel Photoactive Polysaccharides
    Synthesis, characterization and properties of novel photoactive polysaccharides Dissertation zur Erlangung des akademischen Grades doctor rerum naturalium (Dr. rer. nat.) vorgelegt dem Rat der Chemisch-Geowissenschaftlichen Fakultät der Friedrich-Schiller-Universität Jena von Diplom-Chemiker Holger Wondraczek geboren am 20. April 1983 in Jena Gutachter: 1. Prof. Dr. Thomas Heinze (Universität Jena) 2. Prof. Dr. Rainer Beckert (Universität Jena) 3. Prof. Dr. Pedro Fardim (Åbo Akademi University) Tag der öffentlichen Verteidigung: 12.10.2012 Contents List of Figures vii List of Tables xi 1. Introduction 1 I. General Part 3 2. Light for the characterization of polysaccharides and polysaccharide derivatives 5 2.1. Structure of polysaccharides . 6 2.2. Light absorption by polysaccharides . 9 2.3. Fluorescence of polysaccharides and polysaccharide derivatives . 11 3. Photoreactions of polysaccharides and polysaccharide derivatives 17 3.1. Photocrosslinking . 17 3.2. Photochromic polysaccharide derivatives . 19 3.2.1. Polysaccharides containing trans–cis isomerizable chromophores 20 3.2.2. Polysaccharide derivatives forming ionic structures upon irra- diation . 25 II. Special Part 29 4. UV-Vis spectroscopy for the characterization of novel polysaccharide derivatives 31 4.1. Synthesis of aminocellulose sulfates as novel zwitterionic polymers . 31 4.2. Characterization of tosyl cellulose sulfates and aminocellulose sulfates 34 iii Contents 5. Tailored synthesis and structure characterization of new highly func- tionalized photoactive polysaccharide derivatives 39 5.1. Photoactive polysaccharide esters . 39 5.1.1. Synthesis . 39 5.1.2. Characterization . 40 5.2. Synthesis of photoactive polysaccharide polyelectrolytes . 47 5.2.1. Mixed 2-[(4-methyl-2-oxo-2H -chromen-7-yl)oxy]acetic acid- sul- furic acid half esters of dextran and pullulan .
    [Show full text]
  • Characterization of Extracellular Polymeric Substance Producing Isolates from Wastewaters and Their Antibacterial Prospective
    Journal of Applied Biology & Biotechnology Vol. 7(06), pp. 56-62, Nov-Dec, 2019 Available online at http://www.jabonline.in DOI: 10.7324/JABB.2019.70609 Characterization of extracellular polymeric substance producing isolates from wastewaters and their antibacterial prospective Anita Rani Santal1*, Nater Pal Singh2, Tapan Kumar Singha1 1Department of Microbiology, Maharshi Dayanand University, Rohtak, India 2Centre for Biotechnology, Maharshi Dayanand University, Rohtak, India ARTICLE INFO ABSTRACT Article history: Bacteria have the ability of biofilm formation, in which the cells attach to each other within a self-produced Received on: April 22, 2019 matrix of extracellular polymeric substance (EPS). The aim of the present research work was to isolate Accepted on: June 04, 2019 EPS-producing bacteria from wastewater. Total 21 bacterial isolates were screened for EPS production based Available online: November 12, 2019 on mucoid and slimy colonies. Out of 21 isolates, nine efficient isolates were selected for the production of EPS. These efficient bacterial strains were also checked for their antimicrobial potential against Salmonella sp., Escherichia coli, and Klebsiella sp. The isolates ASA3, H2E7, H2F8, and ASB4 inhibited the growth of Key words: Salmonella sp., E. coli, and Klebsiella sp, while isolate ASB5, H2C6, and H2E9 only showed inhibitory effects Extracellular polymeric substance, against Salmonella sp. The maximum concentration of EPS (i.e., 17.2 g/l) was produced by strain ASB4 within antibacterial activity, wastewater, 3 days of incubation. biofilm. 1. INTRODUCTION such as dextran, xanthan, pullulan, gellan, and hyaluronic Today, biopolymers are in great demand for their various acid [10]. The EPS also have been reported to be generally applications and extracellular polymeric substance (EPS) recognized as safe compounds [11].
    [Show full text]
  • Degradation Kinetics and Shelf Life of N-Acetylneuraminic Acid at Different
    molecules Article Degradation Kinetics and Shelf Life of N-acetylneuraminic Acid at Different pH Values Weiwei Zhu 1,2, Xiangsong Chen 1,2, Lixia Yuan 1,*, Jinyong Wu 1 and Jianming Yao 1,* 1 Institute of Plasma Physics, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China; [email protected] (W.Z.); [email protected] (X.C.); [email protected] (J.W.) 2 University of Science and Technology of China, Hefei 230026, China * Correspondence: [email protected] (L.Y.); [email protected] (J.Y.) Received: 18 September 2020; Accepted: 2 November 2020; Published: 5 November 2020 Abstract: The objective of this study was to investigate the stability and degradation kinetics of N-acetylneuraminic acid (Neu5Ac). The pH of the solution strongly influenced the stability of Neu5Ac, which was more stable at neutral pH and low temperatures. Here, we provide detailed information on the degradation kinetics of Neu5Ac at different pH values (1.0, 2.0, 11.0 and 12.0) and temperatures (60, 70, 80 and 90 ◦C). The study of the degradation of Neu5Ac under strongly acidic conditions (pH 1.0–2.0) is highly pertinent for the hydrolysis of polysialic acid. The degradation kinetics of alkaline deacetylation were also studied. Neu5Ac was highly stable at pH 3.0–10.0, even at high temperature, but the addition of H2O2 greatly reduced its stability at pH 5.0, 7.0 and 9.0. Although Neu5Ac has a number of applications in products of everyday life, there are no reports of rigorous shelf-life studies.
    [Show full text]
  • Ii- Carbohydrates of Biological Importance
    Carbohydrates of Biological Importance 9 II- CARBOHYDRATES OF BIOLOGICAL IMPORTANCE ILOs: By the end of the course, the student should be able to: 1. Define carbohydrates and list their classification. 2. Recognize the structure and functions of monosaccharides. 3. Identify the various chemical and physical properties that distinguish monosaccharides. 4. List the important monosaccharides and their derivatives and point out their importance. 5. List the important disaccharides, recognize their structure and mention their importance. 6. Define glycosides and mention biologically important examples. 7. State examples of homopolysaccharides and describe their structure and functions. 8. Classify glycosaminoglycans, mention their constituents and their biological importance. 9. Define proteoglycans and point out their functions. 10. Differentiate between glycoproteins and proteoglycans. CONTENTS: I. Chemical Nature of Carbohydrates II. Biomedical importance of Carbohydrates III. Monosaccharides - Classification - Forms of Isomerism of monosaccharides. - Importance of monosaccharides. - Monosaccharides derivatives. IV. Disaccharides - Reducing disaccharides. - Non- Reducing disaccharides V. Oligosaccarides. VI. Polysaccarides - Homopolysaccharides - Heteropolysaccharides - Carbohydrates of Biological Importance 10 CARBOHYDRATES OF BIOLOGICAL IMPORTANCE Chemical Nature of Carbohydrates Carbohydrates are polyhydroxyalcohols with an aldehyde or keto group. They are represented with general formulae Cn(H2O)n and hence called hydrates of carbons.
    [Show full text]
  • Anti-Cancer Effect of Polysaccharides Isolated from Higher Basidiomycetes Mushrooms
    African Journal of Biotechnology Vol. 2 (12), pp. 672-678, December 2003 Available online at http://www.academicjournals.org/AJB ISSN 1684–5315 © 2003 Academic Journals Takashi Mizuno (1931-2000) Professor Emeritus of Shizuoka University This article is written in memory of Professor Takashi Mizuno who died in May 2000. He had focused a lifetime of research upon development of various antitumor substances from medicinal mushrooms, and is considered th one of the 20 century greatest scientist in his field. Mizuno proved that many polysaccharides with antitumor and immunopotentiating qualities were synthesised in cultured mycelia no less and in fact often better than in fruiting bodies. This result virtually revolutionised mushroom producing and processing business. “Medicine and food both originate from the same root” is a Japanese proverb Mizuno often quoted. Minireview Anti-cancer effect of polysaccharides isolated from higher basidiomycetes mushrooms A.S. Dabaλ and O.U.Ezeronye* Division of Medical Biochemistry, Molecular Biology Laboratory, Faculty of Health Sciences, University of Cape Town, Observatory Cape Town, South Africa. Accepted 24 November 2003 Anti-tumor activity of mushroom fruit bodies and mycelial extracts evaluated using different cancer cell lines. These polysaccharide extracts showed potent antitumor activity against sarcoma 180, mammary adenocarcinoma 755, leukemia L-1210 and a host of other tumors. The antitumor activity was mainly due to indirect host mediated immunotherapeutic effect. These studies are still in progress in many laboratories and the role of the polysaccharides as immunopotentiators is especially under intense debate. The purpose of the present review is to summarize the available information in this area and to indicate the present status of the research.
    [Show full text]